Drug interactions with diosmectite: a study using the artificial stomach–duodenum model

Abstract Drug interactions with diosmectite, a gastric-protective drug, were studied in vitro using an artificial stomach–duodenum model. The behavior of neutral and ionisable drugs with p K a values ranging between 2 and 8 was monitored to determine the physicochemical characteristics of the interactions. The main neutral (digoxin) and acid (valproic acid) drug substances were moderately fixed by clay ( K a 62%), and fully released under neutral conditions. Amphoteric (fluoroquinolones) and basic compounds with a p K a ≥7 (ranitidine, pyrimethamine) were adsorbed by more than 81% by diosmectite in gastric and duodenal compartments. In the part of the model representing the distal duodenum, the potential site for drug absorption, only the active substances which remained positively charged (amphoteric and basic compounds) showed a large reduction (≥80%) in their available free fraction. Ionisation of drug substances administered per os concomitantly with diosmectite plays a crucial role in these interactions.